I started my career in the field of supply chain managememt of clinical studies. I gained insights both from a vendor perspective, working with various customers, as well as from the other side, namely a pharmaceutical company which needs her drugs to be at the right place, at the right time in order to treat its patients.
After that, I gained a profound expertise in late phase studies: post-marketing studies, regisitries, (non-interventional) observational studies and particularly Investigator Initiated Trials.
My expertise go from FIH to phase 4 clinical trials. From small studies with only a few patients enrolled to multi-country, double-blind, placebo and / or comparator controlled studies enrolling several hundreds of patients.
I have been leading as well full portofolios of studies conducted in different clinical study programms within various disease areas (e.g haematology, neuroscience & rare diseases, established products, incl. compassionate use programm and real-world evidence (RWE) and outcome research).
Disease area expertise
Spoken languages
Haemato-oncology Lymphomas (NHL, DLBCL, FL, mantle cell), Leukaemia (CLL)
Rare Diseases Pulmonary Arterial Hypertension (PAH), Gaucher Disease, Spinal
Muscular Atrophy (SMA)
Neuroscience Alzheimer, Parkinson, Multiple Sclerosis, Neuromyelitis, Optica
Spectrum Disorder (NMOSD)
Inflammatory & Autoimmune Diseases Rheumatoid Arthritis, Granulomatosis,
Pemphigus
Solid cancers e.g lung, colorectal, breast cancer, carcinomas, etc
Experience with radioactive tracers for diagnostic purposes
This list is not exhaustive
French mother tongue
(Swiss) German fluent, C2
English fluent, C1
Spanish basic knowledge, B1/B2
Portuguese basic knowledge, A1/A2
Overview of my relevant diplomas
